Fair Value Calculator Fair Value Calculator
EN DE

HARYNACAP (HARYNACAP) Fair Value & Analysis

IN · Market cap ₹725M

H HARYNACAP HARYNACAP · BSE
Price₹139.20
Fair Value₹193.34
Upside+38.9%
Quality44/100
Watch HARYNACAP for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹145.07 – ₹241.60

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price −5.9% over the past month.

Price vs Fair Value (12 months)

₹213.35 ₹120.00 Fair Value ₹193.34 Jul 2025 Jul 2026

12‑month range ₹120.00 – ₹213.35 · fair‑value band ₹145.07 – ₹241.60 · the ₹139.20 price screens below the ₹193.34 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HARYNACAP (HARYNACAP) currently trades at ₹139.20, while our model-based Fair Value estimate is ₹193.34 — implying the stock looks roughly 38.9% undervalued today. We read business quality at 44/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, HARYNACAP generated revenue of ₹129M at a net margin of 75.9%. It earns a return on equity of 3.1%. The stock trades on a trailing P/E of 7.4. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹145.07 (bear case) to ₹241.60 (bull case); at ₹139.20, the current price sits below that range. The share trades about 38% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹129M
Revenue growth (YoY) +1,347%
Net margin 75.9%
Return on equity 3.1%
Free cash flow −₹5.5M FY2026
P/E ratio 7.4
More key figures
Operating margin 96.7%
EPS (TTM) ₹18.74
EPS growth (YoY) +1,816%

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HARYNACAP reported revenue of ₹64.4M in FY2026 versus ₹20.7M in FY2022, a compound +32.9%/yr. Reported net income was ₹97.6M in FY2026, compounding +72.9%/yr from FY2022.

Revenue +32.9%/yr
FY22 ₹20.7M
FY23 ₹27.4M
FY24 ₹43.9M
FY25 ₹75.3M
FY26 ₹64.4M
Net income +72.9%/yr
FY22 ₹10.9M
FY23 ₹15.7M
FY24 ₹28.2M
FY25 ₹52.2M
FY26 ₹97.6M

Is HARYNACAP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "HARYNACAP Fair Value". https://www.fairvalue-calculator.com/stock/HARYNACAP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is HARYNACAP (HARYNACAP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹193.34 versus a price of ₹139.20 — about +39% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HARYNACAP?
Our model-based fair value for HARYNACAP is ₹193.34 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹139.20.
What is the quality score of HARYNACAP?
HARYNACAP has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of HARYNACAP (HARYNACAP)?
HARYNACAP reported trailing-twelve-month revenue of about ₹129M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of HARYNACAP?
The net profit margin of HARYNACAP is about 75.9%, meaning it keeps roughly 75.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.